Progression-Free Survival

Known as: Progression Free Survival, PFS, Progression-Free Survivals 
The length of time during and after treatment in which a patient is living with a disease that does not get worse. Progression-free survival may be… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
BACKGROUND Nivolumab has been associated with longer overall survival than docetaxel among patients with previously treated non… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
Review
2017
Review
2017
OBJECTIVES Efficient use of nivolumab in non-small-cell lung cancer (NSCLC) has been limited by the lack of a definitive… (More)
Is this relevant?
Review
2017
Review
2017
Lung cancer is the foremost cause of cancer-related deaths world-wide. Both, the major forms of lung cancer, Non-small cell lung… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE A randomized, phase III trial demonstrated superiority of sunitinib over interferon alfa (IFN-alpha) in progression-free… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Previous, uncontrolled studies have suggested that first-line treatment with gefitinib would be efficacious in… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE As treatment options expand for metastatic colorectal cancer (mCRC), a blood marker with a prognostic and predictive role… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
PURPOSE Anaplastic oligodendrogliomas are more responsive to chemotherapy than high-grade astrocytomas. We investigated, in a… (More)
  • figure 1
  • table 2
  • table 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND We tested the hypothesis that the level of circulating tumor cells can predict survival in metastatic breast cancer… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Although tumor-infiltrating T cells have been documented in ovarian carcinoma, a clear association with clinical… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
1985
Highly Cited
1985
Eighty-nine patients with untreated primary neuroblastomas were studied to determine the relation between the number of copies of… (More)
Is this relevant?